Photobiostimulation Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||922058|
|出版日期||內容資訊||英文 111 Pages
|全球光生物刺激市場:成長，趨勢，及預測 Photobiostimulation Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 111 Pages||
The photobiostimulation market studied is anticipated to grow with a CAGR of 6.3%, during the forecast period. The significant factor attributing this market's growth is the growing incidence of chronic diseases which is leading to an increase in the number of patients being treated using methods of photobiostimulation. Additional factors such as the rising prevalence of chronic pain in disorders such as arthritis, osteoporosis, and rising geriatric population will drive the market for photobiostimulation during the forecast period.
The continued growth of the number of non-invasive treatments need for less expensive treatment options have an impact on the growth of the photobiostimulation market. Advancement in technology and ensuring maximum patient convenience after and during therapy, are the other factors expected to drive the growth of photobiostimulation market.
Photobiostimulants are being used to minimize tissue damage and to reduce swelling, pain, and oedema, to treat deeper skin wounds, and nerves. Photobiostimulation therapy is also known as low-level light therapy.
Pain Management is Expected to Hold the Largest Market Share in the Photobiostimulation Market
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall photobiostimulation market, throughout the forecast period. This is owing to factors such as the rising prevalence of chronic disorders and related pain such as arthritis, rising geriatric population, and growing demand for noninvasive treatments that will drive the market for the photobiostimulation market in the region. As per the CDC (CENTERS FOR DISEASE CONTROL AND PREVENTION) estimates, by 2040, it is expected that around 78 million (26%) US people aged 18 years or older would have arthritis, which is expected to upsurge the demand of photobiostimulation as the noninvasive treatment are on-demand which is further boosting the market growth.
The Photobiostimulation market is moderately competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and new product launches with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are BioLight Technologies LLC, Thor Photomedicine Ltd, Bioflex Laser Therapy, BioCare Systems, Inc., and Erchonia Corporation.